BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hirano M, Emmanuele V, Quinzii CM. Emerging therapies for mitochondrial diseases. Essays Biochem 2018;62:467-81. [PMID: 29980632 DOI: 10.1042/EBC20170114] [Cited by in Crossref: 59] [Cited by in F6Publishing: 25] [Article Influence: 14.8] [Reference Citation Analysis]
Number Citing Articles
1 Nicolas E, Tricarico R, Savage M, Golemis EA, Hall MJ. Disease-Associated Genetic Variation in Human Mitochondrial Protein Import. Am J Hum Genet 2019;104:784-801. [PMID: 31051112 DOI: 10.1016/j.ajhg.2019.03.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
2 Hussain SA, Yalvac ME, Khoo B, Eckardt S, McLaughlin KJ. Adapting CRISPR/Cas9 System for Targeting Mitochondrial Genome. Front Genet 2021;12:627050. [PMID: 33889176 DOI: 10.3389/fgene.2021.627050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Domínguez-González C, Hernández-Laín A, Rivas E, Hernández-Voth A, Sayas Catalán J, Fernández-Torrón R, Fuiza-Luces C, García García J, Morís G, Olivé M, Miralles F, Díaz-Manera J, Caballero C, Méndez-Ferrer B, Martí R, García Arumi E, Badosa MC, Esteban J, Jimenez-Mallebrera C, Encinar AB, Arenas J, Hirano M, Martin MÁ, Paradas C. Late-onset thymidine kinase 2 deficiency: a review of 18 cases. Orphanet J Rare Dis 2019;14:100. [PMID: 31060578 DOI: 10.1186/s13023-019-1071-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
4 Zhu P, Ma H, Cui S, Zhou X, Xu W, Yu J, Li J. ZLN005 Alleviates In Vivo and In Vitro Renal Fibrosis via PGC-1α-Mediated Mitochondrial Homeostasis. Pharmaceuticals 2022;15:434. [DOI: 10.3390/ph15040434] [Reference Citation Analysis]
5 Trisolini L, Gambacorta N, Gorgoglione R, Montaruli M, Laera L, Colella F, Volpicella M, De Grassi A, Pierri CL. FAD/NADH Dependent Oxidoreductases: From Different Amino Acid Sequences to Similar Protein Shapes for Playing an Ancient Function. J Clin Med 2019;8:E2117. [PMID: 31810296 DOI: 10.3390/jcm8122117] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
6 Yamada Y, Satrialdi, Hibino M, Sasaki D, Abe J, Harashima H. Power of mitochondrial drug delivery systems to produce innovative nanomedicines. Adv Drug Deliv Rev 2020;154-155:187-209. [PMID: 32987095 DOI: 10.1016/j.addr.2020.09.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
7 Lee IC, Chiang KL. Clinical Diagnosis and Treatment of Leigh Syndrome Based on SURF1: Genotype and Phenotype. Antioxidants (Basel) 2021;10:1950. [PMID: 34943053 DOI: 10.3390/antiox10121950] [Reference Citation Analysis]
8 Fan HC, Lee HF, Yue CT, Chi CS. Clinical Characteristics of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes. Life (Basel) 2021;11:1111. [PMID: 34832987 DOI: 10.3390/life11111111] [Reference Citation Analysis]
9 Ramón J, Vila-Julià F, Molina-Granada D, Molina-Berenguer M, Melià MJ, García-Arumí E, Torres-Torronteras J, Cámara Y, Martí R. Therapy Prospects for Mitochondrial DNA Maintenance Disorders. Int J Mol Sci 2021;22:6447. [PMID: 34208592 DOI: 10.3390/ijms22126447] [Reference Citation Analysis]
10 Fontecha-Barriuso M, Martin-Sanchez D, Martinez-Moreno JM, Monsalve M, Ramos AM, Sanchez-Niño MD, Ruiz-Ortega M, Ortiz A, Sanz AB. The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases. Biomolecules 2020;10:E347. [PMID: 32102312 DOI: 10.3390/biom10020347] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
11 Verhagen JMA, Burger J, Bekkers JA, den Dekker AT, von der Thüsen JH, Zajec M, Brüggenwirth HT, van der Sterre MLT, van den Born M, Luider TM, van IJcken WFJ, Wessels MW, Essers J, Roos-Hesselink JW, van der Pluijm I, van de Laar IMBH, Brosens E. Multi-Omics Profiling in Marfan Syndrome: Further Insights into the Molecular Mechanisms Involved in Aortic Disease. Int J Mol Sci 2021;23:438. [PMID: 35008861 DOI: 10.3390/ijms23010438] [Reference Citation Analysis]
12 Almannai M, El-Hattab AW, Ali M, Soler-Alfonso C, Scaglia F. Clinical trials in mitochondrial disorders, an update. Mol Genet Metab 2020;131:1-13. [PMID: 33129691 DOI: 10.1016/j.ymgme.2020.10.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
13 Orsucci D, Ienco EC, Montano V, Siciliano G, Mancuso M. Mitochondrial stroke-like episodes: the search for new therapies. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106228] [Reference Citation Analysis]
14 Hernández-cuervo H, Soundararajan R, Sidramagowda Patil S, Breitzig M, Alleyn M, Galam L, Lockey R, Uversky VN, Kolliputi N. BMI1 Silencing Induces Mitochondrial Dysfunction in Lung Epithelial Cells Exposed to Hyperoxia. Front Physiol 2022;13:814510. [DOI: 10.3389/fphys.2022.814510] [Reference Citation Analysis]
15 Glaubitz S, Schmidt K, Zschüntzsch J, Schmidt J. Myalgia in myositis and myopathies. Best Pract Res Clin Rheumatol 2019;33:101433. [PMID: 31590993 DOI: 10.1016/j.berh.2019.101433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
16 Nesci S. Cellular metabolism therapy. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03514-4] [Reference Citation Analysis]
17 Orsucci D, Ienco EC, Siciliano G, Mancuso M. Mitochondrial disorders and drugs: what every physician should know. Drugs Context 2019;8:212588. [PMID: 31391854 DOI: 10.7573/dic.212588] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
18 Hanaford AR, Cho YJ, Nakai H. AAV-vector based gene therapy for mitochondrial disease: progress and future perspectives. Orphanet J Rare Dis 2022;17:217. [PMID: 35668433 DOI: 10.1186/s13023-022-02324-7] [Reference Citation Analysis]
19 Muthaffar OY. Treating epilepsy with options other than antiepileptic medications. Neurosciences (Riyadh) 2020;25:253-61. [PMID: 33130805 DOI: 10.17712/nsj.2020.4.20200010] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Na J, Kim HD, Lee Y. Effective application of corpus callosotomy in pediatric intractable epilepsy patients with mitochondrial dysfunction. Ther Adv Neurol Disord 2022;15:175628642210925. [DOI: 10.1177/17562864221092551] [Reference Citation Analysis]
21 DiMauro S. A Brief History of Mitochondrial Pathologies. Int J Mol Sci 2019;20:E5643. [PMID: 31718067 DOI: 10.3390/ijms20225643] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Suárez-rivero JM, Pastor-maldonado CJ, Romero-gonzález A, Gómez-fernandez D, Povea-cabello S, Álvarez-córdoba M, Villalón-garcía I, Talaverón-rey M, Suárez-carrillo A, Munuera-cabeza M, Sánchez-alcázar JA. Pterostilbene in Combination With Mitochondrial Cofactors Improve Mitochondrial Function in Cellular Models of Mitochondrial Diseases. Front Pharmacol 2022;13:862085. [DOI: 10.3389/fphar.2022.862085] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Djouadi F, Bastin J. Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies. Cells 2019;8:E289. [PMID: 30925787 DOI: 10.3390/cells8040289] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
24 Sequiera GL, Srivastava A, Sareen N, Yan W, Alagarsamy KN, Verma E, Aghanoori MR, Aliani M, Kumar A, Fernyhough P, Rockman-Greenberg C, Dhingra S. Development of iPSC-based clinical trial selection platform for patients with ultrarare diseases. Sci Adv 2022;8:eabl4370. [PMID: 35394834 DOI: 10.1126/sciadv.abl4370] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Moos WH, Faller DV, Glavas IP, Harpp DN, Kamperi N, Kanara I, Kodukula K, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Sampani K, Steliou K, Tamvakopoulos C, Vavvas DG, Zamboni RJ, Chen X. Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury. Biochem Pharmacol 2022;203:115168. [PMID: 35835206 DOI: 10.1016/j.bcp.2022.115168] [Reference Citation Analysis]
26 Saldana-Caboverde A, Nissanka N, Garcia S, Lombès A, Diaz F. Hypoxia Promotes Mitochondrial Complex I Abundance via HIF-1α in Complex III and Complex IV Eficient Cells. Cells 2020;9:E2197. [PMID: 33003371 DOI: 10.3390/cells9102197] [Reference Citation Analysis]
27 de Barcelos IP, Emmanuele V, Hirano M. Advances in primary mitochondrial myopathies. Curr Opin Neurol 2019;32:715-21. [PMID: 31408013 DOI: 10.1097/WCO.0000000000000743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Wang Y, Hekimi S. Minimal mitochondrial respiration is required to prevent cell death by inhibition of mTOR signaling in CoQ-deficient cells. Cell Death Discov 2021;7:201. [PMID: 34349107 DOI: 10.1038/s41420-021-00591-0] [Reference Citation Analysis]
29 McCormick EM, Zolkipli-Cunningham Z, Falk MJ. Mitochondrial disease genetics update: recent insights into the molecular diagnosis and expanding phenotype of primary mitochondrial disease. Curr Opin Pediatr 2018;30:714-24. [PMID: 30199403 DOI: 10.1097/MOP.0000000000000686] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 7.7] [Reference Citation Analysis]
30 Sharma R, Reinstadler B, Engelstad K, Skinner OS, Stackowitz E, Haller RG, Clish CB, Pierce K, Walker MA, Fryer R, Oglesbee D, Mao X, Shungu DC, Khatri A, Hirano M, De Vivo DC, Mootha VK. Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity. J Clin Invest 2021;131:136055. [PMID: 33463549 DOI: 10.1172/JCI136055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
31 Heinen-Weiler J, Hasenberg M, Heisler M, Settelmeier S, Beerlage AL, Doepper H, Walkenfort B, Odersky A, Luedike P, Winterhager E, Rassaf T, Hendgen-Cotta UB. Superiority of focused ion beam-scanning electron microscope tomography of cardiomyocytes over standard 2D analyses highlighted by unmasking mitochondrial heterogeneity. J Cachexia Sarcopenia Muscle 2021;12:933-54. [PMID: 34120411 DOI: 10.1002/jcsm.12742] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Li J, Zhang W, Cui Z, Li Z, Jiang T, Meng H. Epilepsy Associated With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes. Front Neurol 2021;12:675816. [PMID: 34177782 DOI: 10.3389/fneur.2021.675816] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Tinker RJ, Lim AZ, Stefanetti RJ, McFarland R. Current and Emerging Clinical Treatment in Mitochondrial Disease. Mol Diagn Ther 2021;25:181-206. [PMID: 33646563 DOI: 10.1007/s40291-020-00510-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
34 Coppi L, Ligorio S, Mitro N, Caruso D, De Fabiani E, Crestani M. PGC1s and Beyond: Disentangling the Complex Regulation of Mitochondrial and Cellular Metabolism. Int J Mol Sci 2021;22:6913. [PMID: 34199142 DOI: 10.3390/ijms22136913] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Reynolds E, Byrne M, Ganetzky R, Parikh S. Pediatric single large-scale mtDNA deletion syndromes: The power of patient reported outcomes. Mol Genet Metab 2021;134:301-8. [PMID: 34862134 DOI: 10.1016/j.ymgme.2021.11.004] [Reference Citation Analysis]
36 Koňaříková E, Marković A, Korandová Z, Houštěk J, Mráček T. Current progress in the therapeutic options for mitochondrial disorders. Physiol Res 2020;69:967-94. [PMID: 33129249 DOI: 10.33549/physiolres.934529] [Reference Citation Analysis]
37 Klein IL, van de Loo KFE, Hoogeboom TJ, Janssen MCH, Smeitink JAM, van der Veer E, Verhaak CM, Custers JAE. Blended cognitive behaviour therapy for children and adolescents with mitochondrial disease targeting fatigue (PowerMe): study protocol for a multiple baseline single case experiment. Trials 2021;22:177. [PMID: 33648576 DOI: 10.1186/s13063-021-05126-7] [Reference Citation Analysis]
38 Björkman K, Vissing J, Østergaard E, Bindoff LA, de Coo IFM, Engvall M, Hikmat O, Isohanni P, Kollberg G, Lindberg C, Majamaa K, Naess K, Uusimaa J, Tulinius M, Darin N. Phenotypic spectrum and clinical course of single large-scale mitochondrial DNA deletion disease in the paediatric population: a multicentre study. J Med Genet 2021:jmedgenet-2021-108006. [PMID: 34872991 DOI: 10.1136/jmedgenet-2021-108006] [Reference Citation Analysis]
39 Faria R, Paul M, Biswas S, Vivès E, Boisguérin P, Sousa Â, Costa D. Peptides vs. Polymers: Searching for the Most Efficient Delivery System for Mitochondrial Gene Therapy. Pharmaceutics 2022;14:757. [DOI: 10.3390/pharmaceutics14040757] [Reference Citation Analysis]
40 Allouche S, Schaeffer S, Chapon F. [Mitochondrial diseases in adults: An update]. Rev Med Interne 2021;42:541-57. [PMID: 33455836 DOI: 10.1016/j.revmed.2020.12.002] [Reference Citation Analysis]
41 Schlieben LD, Prokisch H. The Dimensions of Primary Mitochondrial Disorders. Front Cell Dev Biol 2020;8:600079. [PMID: 33324649 DOI: 10.3389/fcell.2020.600079] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
42 Douiev L, Sheffer R, Horvath G, Saada A. Bezafibrate Improves Mitochondrial Fission and Function in DNM1L-Deficient Patient Cells. Cells 2020;9:E301. [PMID: 32012656 DOI: 10.3390/cells9020301] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
43 Maresca A, Del Dotto V, Romagnoli M, La Morgia C, Di Vito L, Capristo M, Valentino ML, Carelli V; ER-MITO Study Group. Expanding and validating the biomarkers for mitochondrial diseases. J Mol Med (Berl) 2020;98:1467-78. [PMID: 32851462 DOI: 10.1007/s00109-020-01967-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
44 Turkheimer FE, Selvaggi P, Mehta MA, Veronese M, Zelaya F, Dazzan P, Vernon AC. Normalizing the Abnormal: Do Antipsychotic Drugs Push the Cortex Into an Unsustainable Metabolic Envelope? Schizophr Bull 2020;46:484-95. [PMID: 31755955 DOI: 10.1093/schbul/sbz119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]